Phase I Clinical Trial of Zolmitriptan Transdermal Microporation System Initiated for the Treatment of Acute Migraine

SAN DIEGO, Feb. 23, 2024.  PassPort Technologies, Inc. (PPTI), based in San Diego, initiated a US Phase 1 clinical study of Zolmitriptan PassPort utilizing its proprietary transdermal microporation system, PassPort platform technology. The...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials